Is BMY a good investment in 2026?

Bristol-Myers Squibb trades at a P/E ratio of 17.7, with medium volatility (25.1% annualized). Recent momentum is positive.

What is the risk level of BMY?

Based on 30-day volatility of 25.1%, BMY has MEDIUM risk. Beta of 0.29 indicates lower sensitivity to market movements than average.

Bristol-Myers Squibb (BMY) Stock Analysis & Price Target

Q: Does BMY pay dividends?

Yes, Bristol-Myers Squibb has a dividend yield of 4.12%.

Key Metrics

MARKET CAP

$124.43B

P/E RATIO

17.7

BETA

0.29

Less volatile

DIV YIELD

4.12%

52W HIGH

$63.33

52W LOW

$42.52

VOLATILITY

25.1%

30d annualized

Price Performance

30-DAY PRICE CHART

$55.56 → $61.10+9.97%

30 days agoToday

1-YEAR PERFORMANCE

$59.62 → $61.10+2.5%

BMY | 52-week chartLast updated: 2/27/2026

Healthcare Sector Context

Defensive sector including pharmaceuticals, biotech, medical devices, and healthcare services.

METRIC	BMY	SECTOR AVG	VS SECTOR
P/E Ratio	17.7x	22.0x	↓ 20%
Beta	0.29	0.85	Less volatile
Div Yield	4.12%	1.50%	Above avg
30d Volatility	25.1%	22%	Higher risk

TOP HEALTHCARE PEERS

UNH JNJ PFE

Competitors Analysis

Compare BMY's key metrics against its main healthcare sector competitors.

COMPANY	PRICE	MARKET CAP	SECTOR
BMY(You are here)	$61.10	$124.43B	Healthcare	—
UNH	$286.66	$259.67B	Healthcare	VIEW →
JNJ	$243.47	$586.74B	Healthcare	VIEW →
PFE	$27.10	$154.08B	Healthcare	VIEW →

Click on a competitor to view their full analysis

Technical Analysis

Bristol-Myers Squibb is currently trading at $61.10, which is 3.5% below its 52-week high. With a beta of 0.29, the stock shows lower sensitivity to market movements.

RSI (14)NEUTRAL

30-DAY TRENDBULLISH

VOLUME10.7M(Below avg)

Frequently Asked Questions

Is BMY a good buy right now?

Bristol-Myers Squibb trades at 17.7x earnings. This is near market average. Current risk level is Medium based on 25.1% volatility.

Does BMY pay dividends?

Yes, Bristol-Myers Squibb offers a dividend yield of 4.12%. This translates to approximately $2.52 per share annually.

How volatile is BMY?

With 30-day annualized volatility of 25.1% and beta of 0.29,BMY is classified as Medium risk. The stock tends to be more stable than the market average.

Related Assets

LLYANALYZE →

Eli Lilly and Company

Track BMY Live

Add Bristol-Myers Squibb to your Portfolio Terminal for real-time alerts and risk updates.

OPEN TERMINAL

Last updated: 2/27/2026, 2:03:38 PM